Cargando…

Correction: Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805185/ https://www.ncbi.nlm.nih.gov/pubmed/27008469 http://dx.doi.org/10.1371/journal.pone.0152450

Ejemplares similares

Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers
por: Li, Bob T., et al.
Publicado: (2016)

Correction: Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer
por: Hennessey, Patrick T., et al.
Publicado: (2012)

The Predictive Value of Peripheral Immune Cell Counts for the Presence of Brain Metastases in Stage IV Non-Small-Cell Lung Cancer (NSCLC)
por: Abuelbeh, I, et al.
Publicado: (2022)

Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
por: Gkika, Eleni, et al.
Publicado: (2018)

Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
por: Tan, Wan-Ling, et al.
Publicado: (2018)

Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer
por: Lokk, Kaie, et al.
Publicado: (2017)

Correction: Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis
por: Liu, Kaitai, et al.
Publicado: (2018)

Correction: Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis
por: Schad, Friedemann, et al.
Publicado: (2022)

Correction to: Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

Correction: Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of Rodents
por: Lahmann, Carolina, et al.
Publicado: (2019)

Correction: Clinical Predictors of Survival for Patients with Stage IV Cancer Referred to Radiation Oncology
por: Kao, Johnny, et al.
Publicado: (2015)

Correction: Clinical Predictors of Survival for Patients with Stage IV Cancer Referred to Radiation Oncology
por: Kao, Johnny, et al.
Publicado: (2015)

Correction to: Can a new scoring system reliably predict failed facemask ventilation?
por: Priebe, Hans-Joachim
Publicado: (2021)

Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
por: Zhang, Ao, et al.
Publicado: (2021)

Site of Metastases as Prognostic Factors in Unselected Population of Stage IV Non-Small Cell Lung Cancer
por: Badawy, Ahmed Ashour, et al.
Publicado: (2018)

Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases
por: Lauko, Adam, et al.
Publicado: (2022)

Nomograms predicting cancer-specific survival for stage IV colorectal cancer with synchronous lung metastases
por: Cheng, Pu, et al.
Publicado: (2022)

Correction: Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer
por: Liu, Chengming, et al.
Publicado: (2022)

Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
Publicado: (2021)

Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer
por: Lee, Dong Soo, et al.
Publicado: (2016)

Upfront Brain Treatments Followed by Lung Surgery Improves Survival for Stage IV Non-small Cell Lung Cancer Patients With Brain Metastases: A Large Cohort Analysis
por: He, Xiaopeng, et al.
Publicado: (2021)

Correction: ALK inhibitors in ALK-rearranged nonsmall cell lung cancer with and without brain metastases: systematic review and network meta-analysis
Publicado: (2022)

Correction to: Exploration of serum biomarkers for predicting the response to Inchinkoto (ICKT), a Japanese traditional herbal medicine
por: Uji, Masahito, et al.
Publicado: (2018)

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
por: Schaule, Jana, et al.
Publicado: (2020)

Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases
por: Wang, Chunyu, et al.
Publicado: (2023)

Correction: Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)
por: Li, Meichen, et al.
Publicado: (2023)

Correction: CyberKnife Radiosurgery in Recurrent Brain Metastases: Do the Benefits Outweigh the Risks?
por: Romagna, Alexander, et al.
Publicado: (2019)

Development and validation a radiomics nomogram for diagnosing occult brain metastases in patients with stage IV lung adenocarcinoma
por: Cong, Ping, et al.
Publicado: (2021)

Correction: Radiomics analysis based on CT for the prediction of pulmonary metastases in ewing sarcoma
por: Liu, Ying, et al.
Publicado: (2023)

Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer: Erratum
Publicado: (2016)

Correction: MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer
por: Li, Wanshuai, et al.
Publicado: (2016)

Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma
por: Lämmer, Friederike, et al.
Publicado: (2021)

Correction: Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease
por: Krawczyk, Marcin, et al.
Publicado: (2017)

Correction to: Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer
Publicado: (2022)

Correction to: Failed preoperative vacuum bell therapy does not affect outcomes following minimally invasive repair of pectus excavatum
por: Muff, J. L., et al.
Publicado: (2022)

Correction: VILIP-1 Downregulation in Non-Small Cell Lung Carcinomas: Mechanisms and Prediction of Survival
por: Fu, Jian, et al.
Publicado: (2013)

Correction to: Lung ultrasound predicts clinical course and outcomes in COVID-19 patients
por: Lichter, Yael, et al.
Publicado: (2020)

Management of Stage IV Macular Holes: When Standard Surgery Fails
por: Reis, R., et al.
Publicado: (2012)

Author Correction: Acute and chronic hypoxia differentially predispose lungs for metastases
por: Reiterer, Moritz, et al.
Publicado: (2020)

Correction: Correction: Cerebral Hemodynamic Changes of Mild Traumatic Brain Injury at the Acute Stage
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e14ovsblv8s37pej9u5fg9kj8q